EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

QR Code

EFFECT OF THE COMBINED ANTIHYPERTENSIVE THERAPY WITH TARGET BLOOD PRESSURE ACHIEVEMENT ON INTRARENAL BLOOD FLOW IN PATIENTS WITH TYPE 2 DIABETES

Aim. To compare the dynamics of intrarenal vascular resistance (IRVR), circadian blood pressure (BP) profile and glomerular filtration rate (GFR) in patients with arterial hypertension (HT) and type 2 diabetes mellitus (DM) who achieved the target BP levels (<130/80 mmHg) due to long-term com...

Full description

Saved in:

Bibliographic Details
Main Authors:	O. A. Koshel'skaya, O. A. Zhuravleva
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-12-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	intrarenal vascular resistance diabetes mellitus arterial hypertension target blood pressure combined antihypertensive treatment renin-angiotensin-aldosterone system inhibitors glomerular filtration rate
Online Access:	https://www.rpcardio.online/jour/article/view/464
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Algorithm for differential administration of combination antihypertensive therapy in patients with Type 2 diabetes mellitus
by: O. A. Koshelskaya, et al.
Published: (2013-08-01)

Arterial hypertension progression and changing activity of reninangiotensin-aldosterone and sympatho-adrenal systems
by: Sh. V. Akhadov, et al.
Published: (2010-04-01)

EFFICACY OF COMBINED ANTIHYPERTENSIVE THERAPY IN ACHIEVEMENT OF TARGET BLOOD PRESSURE IN DIABETIC PATIENTS
by: O. A. Koshel'skaya, et al.
Published: (2015-12-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AND REPLICATIVE CELLULAR SENESCENCE: THEIR INTERACTION DURING THE VASCULAR AGEING
by: V. S. Pykhtina, et al.
Published: (2015-09-01)

Prospects of using genetic testing to increase the effectiveness of antihypertensive therapy
by: N. V. Drobotya, et al.
Published: (2020-06-01)

Markers of chronic kidney disease and disorders of renal hemodynamics in patients with medically-controlled arterial hypertension and high and very high cardiovascular risk
by: O. A. Koshel'skaya, et al.
Published: (2018-11-01)

INFLUENCE OF COMORBIDITIES ON BLOOD ALDOSTERONE LEVEL IN CHRONIC HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION OF THE LEFT VENTRICLE
by: N. T. Vatutin, et al.
Published: (2017-12-01)

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2019-07-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Circulating Levels of Angiotensinogen, Sex Hormones, and Hormone Therapy—The Multi‐Ethnic Study of Atherosclerosis (MESA)
by: Karita C. F. Lidani, et al.
Published: (2025-06-01)

Pharmacogenetic aspects of eprosartan therapy and polymorphic markers of renin-angiotensin-aldosterone system genes in Uzbek patients with essential arterial hypertension
by: D. R. Kurbanova, et al.
Published: (2009-06-01)

Myocardial fibrosis and atrial fibrillation
by: S. V. Grigoryan, et al.
Published: (2018-09-01)

ENDOCRINE DISFUNCTION IN WOMEN WITH PRE-ECLAMPSIA AND ALIMENTARY OBESITY
by: A. N. Rymashevskii, et al.
Published: (2017-06-01)

Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
by: Roberto Pecoits-Filho, et al.
Published: (2025-09-01)

Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
by: Roberto Pecoits-Filho, MD, PhD, et al.
Published: (2025-07-01)

A Flexible Regimen of Combination Antihypertensive Therapy for Lower Blood Pressure to the Lower Target Level. Viewpoint of Cardiologist and Clinical Pharmacologist
by: S. R. Gilyarevskiy, et al.
Published: (2019-05-01)

Direct renin inhibitor aliskiren in women with menopausal metabolic syndrome and arterial hypertension
by: Yu. V. Zhernakova, et al.
Published: (2011-08-01)

Heart and pulmonary artery remodeling association with various levels of natriuretic peptides and renin-angiotensin-aldosterone system activation in patients with pulmonary hypertension of various etiology
by: Yu. A. Andreeva, et al.
Published: (2008-12-01)

The functional state of the kallikrein-kinin and renin-angiotensin-aldosterone systems in patients with localized kidney cancer
by: N. D. Ushakova, et al.
Published: (2021-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2012-09-01)

Neurohumoral activation in arterial hypertension pathogenesis among patients with hypoD and hyperthyrosis
by: P. Kh. Dzhanashiya, et al.
Published: (2005-10-01)

Dynamics of renin-angiotensin-aldosteron system and lipid profile in hypertensive hypothyrosis patients during the process of thyroid function compensation
by: P. Kh. Dzhanashiya, et al.
Published: (2004-12-01)

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

The use of mineralocorticoid antagonists in chronic heart failure
by: Andrea Szegedi, et al.
Published: (2025-07-01)

Mechanisms of renal damage in patients with new coronavirus infection (literature review)
by: E. V. Utkina, et al.
Published: (2023-08-01)

THE INFLUENCE OF INDAPAMIDE ON BLOOD PRESSURE DAILY PROFILE, HEMODYNAMICS AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS OLDER THAN 55 YEARS
by: S. V. Shlyk, et al.
Published: (2002-02-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)

Actual issues of the pathogenesis of COVID-19 and possible measures for the prevention of severe forms of the disease
by: Kh. G. Omarova, et al.
Published: (2021-06-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Myocardial functional status in patients with arterial hypertension and hyperaldosteronism: orthogonal electrocardiography assessment
by: Kh. F. Samedova, et al.
Published: (2006-04-01)

Association of decreased glomerular filtration rate with renal hemodynamic disorders and inflammatory biomarkers in patients with medically-controlled hypertension of high cardiovascular risk
by: O. A. Koshelskaya, et al.
Published: (2021-10-01)

SYMPATHO-ADRENAL SYSTEM IN ARTERIAL HYPERTENSION PATIENTS: ACTIVITY ASSESSMENT AND CLINICAL VALUE
by: Sh. V. Akhadov, et al.
Published: (2009-04-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

EVOLUTION STAGES OF LOW RENIN HYPERTENSION
by: S. V. Akhadov, et al.
Published: (2016-01-01)